With strong experience in the life sciences sector, Freshfields Bruckhaus Deringer LLP advises domestic and international clients such as Johnson & Johnson and AstraZeneca on various transactional tax matters, including acquisitions, divestitures, capital markets transactions, and investment strategies. Head of practice Steven Matays joined the group’s New York practice from Skadden, Arps, Slate, Meagher & Flom LLP in June 2024, bringing a wealth of experience in cross-border M&A, complex debt and equity offerings, and joint ventures. In Washington DC, Claude Stansbury advises financial institutions and multinational companies on financings, restructurings, and disposals. Joe Soltis in New York advises on multibillion-dollar deals spanning sectors such as life sciences, manufacturing, and software.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Sanofi
- Johnson & Johnson
- Patrick Whitesell, the Executive Chairman of Endeavor
- Roivant Sciences
- AstraZeneca
- Special Committee of PowerSchool Holdings
- Cinven
- Cencora
- Sonoco Products Company
- Zeus Company
Highlight-Mandate
- Advised Sanofi on its exclusive negotiations with CD&R for the potential purchase and sale of a 50% controlling stake in Opella.
- Advised Johnson & Johnson on the tax aspects of its $13.1bn acquisition of Shockwave Medical.
- Advised the Executive Chairman of Endeavor, in connection with the Company’s pending sale to Silver Lake.
Anwält*innen
Praxisleitung
Steven Matays
Weitere Kernanwält*innen
Claude Stansbury; Joe Soltis; Sarah Katz